Seyoung Seo

Differential protein stability and clinical responses ofEML4-ALK fusion variants to various ALK inhibitors in advancedALK-rearranged non-small cell lung cancer

Chang Gok Woo, Seyoung Seo, Sang Wan Kim et al. · Annals of Oncology · 2016 · 206 citations · Full text

Medicine, Bronchial Neoplasm, Immune Checkpoint Inhibitor +8

Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3)

Seyoung Seo, Min‐Hee Ryu, Young Soo Park et al. · Gastric Cancer · 2018 · 158 citations · Full text

Gastrointestinal Oncology, Medicine, Gastroenterology +7

Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era

Seyoung Seo, Jung Yong Hong, Shinkyo Yoon et al. · Oncotarget · 2016 · 44 citations · Full text

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer

Changhwan Sung, Jinhyeon An, Jaesoon Park et al. · Nature Cancer · 2023 · 38 citations

Cancer Immunosurveillance, Medicine, Checkpoint Blockade Therapy +12

Blockade of CCL2 expression overcomes intrinsic PD-1/PD-L1 inhibitor-resistance in transglutaminase 2-induced PD-L1 positive triple negative breast cancer.

Junyoung Choi, Hee Jin Lee, Shinkyo Yoon et al. · PubMed · 2020 · 36 citations · Full text

Breast Oncology, Immunology, Immune Regulation +18